| pubmed-article:12680177 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12680177 | lifeskim:mentions | umls-concept:C0006142 | lld:lifeskim |
| pubmed-article:12680177 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:12680177 | lifeskim:mentions | umls-concept:C0001554 | lld:lifeskim |
| pubmed-article:12680177 | lifeskim:mentions | umls-concept:C0332174 | lld:lifeskim |
| pubmed-article:12680177 | lifeskim:mentions | umls-concept:C0144576 | lld:lifeskim |
| pubmed-article:12680177 | lifeskim:mentions | umls-concept:C0728747 | lld:lifeskim |
| pubmed-article:12680177 | lifeskim:mentions | umls-concept:C0439590 | lld:lifeskim |
| pubmed-article:12680177 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:12680177 | pubmed:issue | 1B | lld:pubmed |
| pubmed-article:12680177 | pubmed:dateCreated | 2003-4-8 | lld:pubmed |
| pubmed-article:12680177 | pubmed:abstractText | To evaluate the efficacy and safety of weekly paclitaxel and trastuzumab in patients with HER2-positive metastatic breast cancer, with trastuzumab administered beyond disease progression. | lld:pubmed |
| pubmed-article:12680177 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12680177 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12680177 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12680177 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12680177 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12680177 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12680177 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12680177 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12680177 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12680177 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12680177 | pubmed:issn | 0250-7005 | lld:pubmed |
| pubmed-article:12680177 | pubmed:author | pubmed-author:MellorVV | lld:pubmed |
| pubmed-article:12680177 | pubmed:author | pubmed-author:Christodoulou... | lld:pubmed |
| pubmed-article:12680177 | pubmed:author | pubmed-author:SgourosJJ | lld:pubmed |
| pubmed-article:12680177 | pubmed:author | pubmed-author:KlouvasGG | lld:pubmed |
| pubmed-article:12680177 | pubmed:author | pubmed-author:SkarlosD VDV | lld:pubmed |
| pubmed-article:12680177 | pubmed:author | pubmed-author:PateliAA | lld:pubmed |
| pubmed-article:12680177 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12680177 | pubmed:volume | 23 | lld:pubmed |
| pubmed-article:12680177 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12680177 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12680177 | pubmed:pagination | 737-44 | lld:pubmed |
| pubmed-article:12680177 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:12680177 | pubmed:meshHeading | pubmed-meshheading:12680177... | lld:pubmed |
| pubmed-article:12680177 | pubmed:meshHeading | pubmed-meshheading:12680177... | lld:pubmed |
| pubmed-article:12680177 | pubmed:meshHeading | pubmed-meshheading:12680177... | lld:pubmed |
| pubmed-article:12680177 | pubmed:meshHeading | pubmed-meshheading:12680177... | lld:pubmed |
| pubmed-article:12680177 | pubmed:meshHeading | pubmed-meshheading:12680177... | lld:pubmed |
| pubmed-article:12680177 | pubmed:meshHeading | pubmed-meshheading:12680177... | lld:pubmed |
| pubmed-article:12680177 | pubmed:meshHeading | pubmed-meshheading:12680177... | lld:pubmed |
| pubmed-article:12680177 | pubmed:meshHeading | pubmed-meshheading:12680177... | lld:pubmed |
| pubmed-article:12680177 | pubmed:meshHeading | pubmed-meshheading:12680177... | lld:pubmed |
| pubmed-article:12680177 | pubmed:meshHeading | pubmed-meshheading:12680177... | lld:pubmed |
| pubmed-article:12680177 | pubmed:meshHeading | pubmed-meshheading:12680177... | lld:pubmed |
| pubmed-article:12680177 | pubmed:meshHeading | pubmed-meshheading:12680177... | lld:pubmed |
| pubmed-article:12680177 | pubmed:meshHeading | pubmed-meshheading:12680177... | lld:pubmed |
| pubmed-article:12680177 | pubmed:meshHeading | pubmed-meshheading:12680177... | lld:pubmed |
| pubmed-article:12680177 | pubmed:meshHeading | pubmed-meshheading:12680177... | lld:pubmed |
| pubmed-article:12680177 | pubmed:articleTitle | Prolonged administration of weekly paclitaxel and trastuzumab in patients with advanced breast cancer. | lld:pubmed |
| pubmed-article:12680177 | pubmed:affiliation | Oncology Department, Henry Dynan Hospital, Athens, Greece. hecogiat@otenet.gr | lld:pubmed |
| pubmed-article:12680177 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12680177 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12680177 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12680177 | lld:pubmed |
